Taking pain out of ngf: A "painless" ngf mutant, linked to hereditary sensory autonomic neuropathy type v, with full neurotrophic activity

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Capsoni, Simona ^a,b   Covaceuszach, Sonia ^c   Marinelli, Sara ^d   Ceci, Marcello ^a   Bernardo, Antonietta ^e   Minghetti, Luisa ^e   Ugolini, Gabriele ^c   Pavone, Flaminia ^d   Cattaneo, Antonino ^a,b  

^a EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

^c Rotta Research Laboratorium   (Italy)

^d CNR   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A; ARGININE; MUTANT PROTEIN; NERVE GROWTH FACTOR RECEPTOR; TRYPTOPHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NEUROPATHY; NEUROPROTECTION; NEUROTROPISM; NOCICEPTION; NONHUMAN; PROTEIN FUNCTION; RISK FACTOR; SIGNAL TRANSDUCTION; AMINO ACID SUBSTITUTION; ANIMAL; CELL CULTURE; CELL STRAIN; CELL STRAIN 3T3; CHICK EMBRYO; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SENSORY RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMALS; ARGININE; BALB 3T3 CELLS; CELLS, CULTURED; CHICK EMBRYO; GENETIC PREDISPOSITION TO DISEASE; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HUMANS; MALE; MICE; MUTANT PROTEINS; NERVE GROWTH FACTORS; PAIN; PAIN PERCEPTION; PC12 CELLS; RATS; RECEPTOR, NERVE GROWTH FACTOR; SENSORY RECEPTOR CELLS; TRYPTOPHAN;

EID: 79952233342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017321     Document Type: Article

References (68)

1. Levi-Montalcini R, (1952) Effects of mouse tumor transplantation on the nervous system. Ann N Y Acad Sci 55: 330-344.
2. Levi-Montalcini R, (1987) The nerve growth factor 35 years later. Science 237: 1154-1162.
3. Hefti F, (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6: 2155-2162.
4. Mobley WC, Rutkowski JL, Tennekoon GI, Gemski J, Buchanan K, et al. (1986) Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res 387: 53-62.
5. Pezet S, McMahon SB, (2006) Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29: 507-538.
6. Snider WD, McMahon SB, (1998) Tackling pain at the source: new ideas about nociceptors. Neuron 20: 629-632.
7. Ritter AM, Lewin GR, Kremer NE, Mendell LM, (1991) Requirement for nerve growth factor in the development of myelinated nociceptors in vivo. Nature 350: 500-502.
8. Lewin GR, Mendell LM, (1993) Nerve growth factor and nociception. Trends Neurosci 16: 353-359.
9. Chao MV, (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4: 299-309.
10. Doya H, Ohtori S, Fujitani M, Saito T, Hata K, et al. (2005) c-Jun N-terminal kinase activation in dorsal root ganglion contributes to pain hypersensitivity. Biochem Biophys Res Commun 335: 132-138.
11. Malik-Hall M, Dina OA, Levine JD, (2005) Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur J Neurosci 21: 3387-3394.
12. Obata K, Katsura H, Sakurai J, Kobayashi K, Yamanaka H, et al. (2006) Suppression of the p75 neurotrophin receptor in uninjured sensory neurons reduces neuropathic pain after nerve injury. J Neurosci 26: 11974-11986.
13. Bergmann I, Reiter R, Toyka KV, Koltzenburg M, (1998) Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75. Neurosci Lett 255: 87-90.
14. Sawada J, Itakura A, Tanaka A, Furusaka T, Matsuda H, (2000) Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood 95: 2052-2058.
15. Horigome K, Pryor JC, Bullock ED, Johnson EM Jr, (1993) Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem 268: 14881-14887.
16. Kawamoto K, Aoki J, Tanaka A, Itakura A, Hosono H, et al. (2002) Nerve growth factor activates mast cells through the collaborative interaction with lysophosphatidylserine expressed on the membrane surface of activated platelets. J Immunol 168: 6412-6419.
17. Lewin GR, Ritter AM, Mendell LM, (1993) Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13: 2136-2148.
18. Lewin GR, Rueff A, Mendell LM, (1994) Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 6: 1903-1912.
19. Dyck PJ, Peroutka S, Rask C, Burton E, Baker MK, et al. (1997) Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 48: 501-505.
20. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, et al. (1994) The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 36: 244-246.
21. Svensson P, Cairns BE, Wang K, Arendt-Nielsen L, (2003) Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain 104: 241-247.
22. Apfel SC, (2000) Neurotrophic factors and pain. Clin J Pain 16: S7-11.
23. Apfel SC, (2002) Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol 50: 393-413.
24. Eriksdotter Jonhagen M, Nordberg A, Amberla K, Backman L, Ebendal T, et al. (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 9: 246-257.
25. Nicol GD, Vasko MR, (2007) Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks? Mol Interv 7: 26-41.
26. Indo Y, Tsuruta M, Hayashida Y, Karim MA, Ohta K, et al. (1996) Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 13: 485-488.
27. Einarsdottir E, Carlsson A, Minde J, Toolanen G, Svensson O, et al. (2004) A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet 13: 799-805.
28. Carvalho OP, Thornton GK, Hertecant J, Houlden H, Nicholas AK, et al. (2010) A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet doi:10.1136/jmg.2010.081455.
29. de Andrade DC, Baudic S, Attal N, Rodrigues CL, Caramelli P, et al. (2008) Beyond neuropathy in hereditary sensory and autonomic neuropathy type V: cognitive evaluation. Eur J Neurol 15: 712-719.
30. Minde J, Andersson T, Fulford M, Aguierre M, Nennesmo I, et al. (2008) A novel NGFB point mutation, a phenotype study of heterozygous patients. J Neurol Neurosurg Psychiatry.
31. Larsson E, Kuma R, Norberg A, Minde J, Holmberg M, (2009) Nerve growth factor R221W responsible for insensitivity to pain is defectively processed and accumulates as proNGF. Neurobiol Dis 33: 221-228.
32. Covaceuszach S, Capsoni S, Marinelli S, Pavone F, Ceci M, et al. (2010) In vitro receptor binding properties of a painless NGF mutein, linked to hereditary sensory autonomic neuropathy type V. Biochem Biophys Res Commun 391: 824-829.
33. He XL, Garcia KC, (2004) Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304: 870-875.
34. Wehrman T, He X, Raab B, Dukipatti A, Blau H, et al. (2007) Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 53: 25-38.
35. Wiesmann C, Ultsch MH, Bass SH, de Vos AM, (1999) Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401: 184-188.
36. Paoletti F, Covaceuszach S, Konarev PV, Gonfloni S, Malerba F, et al. (2009) Intrinsic structural disorder of mouse proNGF. Proteins 75: 990-1009.
37. Feng D, Kim T, Ozkan E, Light M, Torkin R, et al. (2010) Molecular and structural insight into proNGF engagement of p75NTR and sortilin. J Mol Biol 396: 967-984.
38. Reichardt LF, (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361: 1545-1564.
39. Huang EJ, Reichardt LF, (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72: 609-642.
40. Kaplan DR, Miller FD, (1997) Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 9: 213-221.
41. Zhuang ZY, Xu H, Clapham DE, Ji RR, (2004) Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 24: 8300-8309.
42. Kao S, Jaiswal RK, Kolch W, Landreth GE, (2001) Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 276: 18169-18177.
43. Limpert AS, Karlo JC, Landreth GE, (2007) Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signal-regulated kinase activation through c-Cbl-associated protein. Mol Cell Biol 27: 5686-5698.
44. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV, (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383: 716-719.
45. Sonnenfeld KH, Ishii DN, (1982) Nerve growth factor effects and receptors in cultured human neuroblastoma cell lines. J Neurosci Res 8: 375-391.
46. Covaceuszach S, Capsoni S, Ugolini G, Spirito F, Vignone D, et al. (2009) Development of a non invasive NGF-based therapy for Alzheimer's disease. Curr Alzheimer Res 6: 158-170.
47. Chevalier S, Praloran V, Smith C, MacGrogan D, Ip NY, et al. (1994) Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells. Blood 83: 1479-1485.
48. Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P, (2008) NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons. Proc Natl Acad Sci U S A 105: 13139-13144.
49. Lee X, Yang Z, Shao Z, Rosenberg SS, Levesque M, et al. (2007) NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J Neurosci 27: 220-225.
50. Rotthier A, Baets J, De Vriendt E, Jacobs A, Auer-Grumbach M, et al. (2009) Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 132: 2699-2711.
51. Ryden M, Hempstead B, Ibanez CF, (1997) Differential modulation of neuron survival during development by nerve growth factor binding to the p75 neurotrophin receptor. J Biol Chem 272: 16322-16328.
52. Mahapatra S, Mehta H, Woo SB, Neet KE, (2009) Identification of critical residues within the conserved and specificity patches of nerve growth factor leading to survival or differentiation. J Biol Chem 284: 33600-33613.
53. Wood JN, (2010) Nerve growth factor and pain. N Engl J Med 363: 1572-1573.
54. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, et al. (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411: 957-962.
55. Zhu W, Oxford GS, (2007) Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol Cell Neurosci 34: 689-700.
56. Zhang YH, Nicol GD, (2004) NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor. Neurosci Lett 366: 187-192.
57. Petersen M, Segond von Banchet G, Heppelmann B, Koltzenburg M, (1998) Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75. Neuroscience 83: 161-168.
58. Watanabe T, Ito T, Inoue G, Ohtori S, Kitajo K, et al. (2008) The p75 receptor is associated with inflammatory thermal hypersensitivity. J Neurosci Res 86: 3566-3574.
59. Minde J, Toolanen G, Andersson T, Nennesmo I, Remahl IN, et al. (2004) Familial insensitivity to pain (HSAN V) and a mutation in the NGFB gene. A neurophysiological and pathological study. Muscle Nerve 30: 752-760.
60. Cattaneo A, Capsoni S, Paoletti F, (2008) Towards non invasive Nerve Growth Factor therapies for Alzheimer's disease. Journal of Alzheimer's disease 15: 255-283.
61. Greene LA, Tischler AS, (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73: 2424-2428.
62. Culmsee C, Gerling N, Lehmann M, Nikolova-Karakashian M, Prehn JH, et al. (2002) Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75. Neuroscience 115: 1089-1108.
63. Cattaneo A, Capsoni S, Margotti E, Righi M, Kontsekova E, et al. (1999) Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody. J Neurosci 19: 9687-9697.
64. Barde YA, Edgar D, Thoenen H, (1980) Sensory neurons in culture: changing requirements for survival factors during embryonic development. Proc Natl Acad Sci U S A 77: 1199-1203.
65. LoPresti P, Poluha W, Poluha DK, Drinkwater E, Ross AH, (1992) Neuronal differentiation triggered by blocking cell proliferation. Cell Growth Differ 3: 627-635.
66. Bernardo A, Greco A, Levi G, Minghetti L, (2003) Differential lipid peroxidation, Mn superoxide, and bcl-2 expression contribute to the maturation-dependent vulnerability of oligodendrocytes to oxidative stress. J Neuropathol Exp Neurol 62: 509-519.
67. Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F, (2007) The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci U S A 104: 2985-2990.
68. Luvisetto S, Marinelli S, Cobianchi S, Pavone F, (2007) Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain. Neuroscience 145: 1-4.